Demographic diversity of genetic databases used in Alzheimer's disease research
- PMID: 37093293
- DOI: 10.1007/s00439-023-02551-3
Demographic diversity of genetic databases used in Alzheimer's disease research
Abstract
For several years, experts have warned about the lack of diversity in genetic research databases, and researchers have devoted time and resources to recruiting subjects from underrepresented subgroups. In this study, we review published reports in academic journals of genetic studies of Alzheimer's disease to note whether demographic diversity was indicated in the reports and, if so, the extent of representation of non-European subjects over the period from 1997 to 2022. We use multivariate regression analysis to analyze changes over time and to explain variation across studies. Our analysis indicates that reported diversity has not changed over time. Rather, it appears to have remained relatively constant, since Genome-Wide Association Studies (GWASs) were first used in the 1990s. We find most variation to be across journals rather than within journals, suggesting that characteristics of journals are an important influence on the dissemination of research with diverse samples. Lack of racial diversity in genetic databases used to develop clinical applications could lead to disparities in the effectiveness of those applications for underrepresented groups.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Gout and the risk of Alzheimer's disease: A Mendelian randomization study.Int J Rheum Dis. 2019 Jun;22(6):1046-1051. doi: 10.1111/1756-185X.13548. Epub 2019 Mar 28. Int J Rheum Dis. 2019. PMID: 30924303
-
How understudied populations have contributed to our understanding of Alzheimer's disease genetics.Brain. 2021 May 7;144(4):1067-1081. doi: 10.1093/brain/awab028. Brain. 2021. PMID: 33889936 Free PMC article. Review.
-
Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer's disease.Acta Neuropathol Commun. 2021 May 21;9(1):93. doi: 10.1186/s40478-021-01199-2. Acta Neuropathol Commun. 2021. PMID: 34020725 Free PMC article.
-
Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study.Brain. 2021 Apr 12;144(3):924-937. doi: 10.1093/brain/awaa364. Brain. 2021. PMID: 33188687 Free PMC article.
-
An Overview of Genome-Wide Association Studies in Alzheimer's Disease.Neurosci Bull. 2016 Apr;32(2):183-90. doi: 10.1007/s12264-016-0011-3. Epub 2016 Jan 25. Neurosci Bull. 2016. PMID: 26810783 Free PMC article. Review.
Cited by
-
Editorial for the Neurogenetics and Neurogenomics special issue.Hum Genet. 2023 Aug;142(8):997-999. doi: 10.1007/s00439-023-02585-7. Hum Genet. 2023. PMID: 37474752 No abstract available.
References
-
- Allen AL (1997) Genetic testing, nature, and trust. Seton Hall Law Rev 27:887–892 - PubMed
-
- Alsan M, Durvasala M, Gupta H, Schwartzstein J, Williams HL (2022) Representation and extrapolation: evidence from clinical trials. NBER Working Paper 30575. https://www.nber.org/papers/w30575 . Accessed 13 Nov 2022
-
- Boyd RW, Lindo EG, Weeks LD, McLemore MR (2020) On racism: a new standard for publishing on racial health inequities. Health Aff Forefront. https://doi.org/10.1377/forefront.20200630.939347 - DOI
-
- Cohn EG, Henderson GE, Appelbaum PS (2017) Distributive justice, diversity, and inclusion in precision medicine: what will success look like? Genet Med 19:157–159. https://doi.org/10.1038/gim.2016.92 - DOI - PubMed
-
- Grahan LA, Ngwa J, Ntekim O, Ogunlana O, Wolday S, Johnson S, Johnson M, Castor C, Fungwe TV, Obisesan TO (2018) Best strategies to recruit and enroll elderly Blacks into clinical and biomedical research. Clin Interven Aging 13:43–50. https://doi.org/10.2147/CIA.S130112 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical